PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets tough cancers in major trial
Disease control Not yet recruitingThis study is testing whether adding an experimental drug called IBI343 to other treatments is safe and effective for people with advanced stomach or pancreatic cancer that has a specific marker called CLDN18.2. About 389 participants will receive the combination therapy to see i…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Gene test race: can early screening unlock new cancer treatments?
Disease control Not yet recruitingThis study aims to see if performing a broad genetic test on tumors early in treatment, rather than later, helps find more personalized treatment options for people with advanced pancreatic, liver, or triple-negative breast cancer. It will compare two approaches: one group gets t…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New scan aims to spot hidden cancer spread in the gut
Diagnosis Not yet recruitingThis study is testing a new type of PET/CT scan to see if it can better detect cancer that has spread to the lining of the abdomen (peritoneal carcinomatosis) in patients with certain cancers. About 175 adults with colorectal, gastric, ovarian, or pancreatic cancer who are suspec…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: GE Healthcare • Aim: Diagnosis
Last updated Mar 25, 2026 14:08 UTC